The Women’s Health Market Outlook to 2011

With increased pricing pressure from generics, limited differentiation among new medicines and pipeline products and declining sales growth, the women’s health market is facing threatening competitive forces, prompting major pharmaceutical players to initiate key strategic changes. ‘The Women’s Health Market Outlook to 2011’ is a new report providing analysis of the current and future market for women’s health drugs across all major indications. Forecasts are given based on current marketed portfolio, drivers and resistors of growth and R&D pipelines, enabling you to predict changes in the dynamics of the global women’s health market. Key indications covered in this report are osteoporosis, infertility, uterine fibroids, endometriosis, urinary incontinence and gynecological infections.

Published: April 2007

PDF Format
Table of Contents
Table of Contents (PDF)
Price: $2,875.00 / GBP1,437.50